Al-Modawat Specialized Medical Co. (9594.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Al-Modawat Specialized Medical Co., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | 17.52x | 21.81x | 4.48x | 8.08x | -37.78x |
| P/B Ratio | 3.77x | 1.72x | 2.12x | 2.69x | 4.36x |
| P/S Ratio | 2.73x | 1.75x | 1.12x | 1.42x | 2.04x |
| Profitability | |||||
| Gross Margin | 43.5% | 39.1% | 54.7% | 47.6% | 34.4% |
| Operating Margin | 18.1% | 10.3% | 27.1% | 19.5% | -2.2% |
| Net Margin | 15.6% | 8.0% | 25.0% | 17.6% | -5.4% |
| EBITDA Margin | 18.1% | 10.8% | 27.9% | 22.9% | 3.1% |
| Liquidity | |||||
| Current Ratio | 1.52x | 2.03x | 1.31x | 1.10x | 1.01x |
| Quick Ratio | 1.52x | 1.81x | 1.18x | 0.94x | 0.87x |
| Leverage | |||||
| Debt/Equity | 0.07x | 0.21x | 0.23x | 0.28x | 0.41x |
YoY = year-over-year change. Source: FMP..